Inventaire - your friends and communities are your best library

G1 cell-cycle control and cancer

published in: Nature

date of publication: 2004-11-01

language: English

Cites articles 96

Date

Title

Authors

2004-01

Recycling the Cell Cycle
2004-01-01

Dynamics of pre-replication complex proteins during the cell division cycle

Juan Méndez, Bruce William Stillman, Kannanganattu V Prasanth
2004-01-23

Principles of tumor suppression
2004-08-01

Mouse development and cell proliferation in the absence of D-cyclins

Maria Ciemerych-Litwinienko, Ciemerych MA, Vivienne I Rebel, Shoumo Bhattacharya
2004-08-01

Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6

Marcos Malumbres, Rocio Sotillo, Javier Galán
2004-03-11

Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase

Daniele Guardavaccaro, Michele Pagano, Nicolino Valerio Dorrello, Tarig Bashir, Virginia Amador
2004-03-11

Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex

William G. Kaelin
2004-11-21

Autonomous regulation of the anaphase-promoting complex couples mitosis to S-phase entry

Michael Rape
2004-01-01

Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems
2004-05-01

RAS and RHO GTPases in G1-phase cell-cycle regulation

Mathew L Coleman, Michael F. Olson
2004-05-01

The discovery of receptor tyrosine kinases: targets for cancer therapy
2004-03-01

Protein kinase inhibitors: insights into drug design from structure

Martin Noble, Louise Johnson
2004-06-01

Tyrosine kinase inhibitors: why does the current process of clinical development not apply to them?

Josep Baselga
2004-05

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004-06-04

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

Heidi Greulich, Stacey Gabriel, Matthew Meyerson, Pasi A Jänne, Titus J Boggon
2004-09-07

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Harold E. Varmus, William Pao, Lucinda Fulton, Elaine Mardis, Mark G Kris, Valerie W Rusch, Katerina Politi
2004-01-23

Cell death: critical control points

Stanley J. Korsmeyer
2004-01-01

Cytochrome C-mediated apoptosis
2004-04-16

IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a

Mien-Chie Hung
2004-05

The TOR pathway: a target for cancer therapy
2004-02-25

LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1

Maria Deak, Jérôme Boudeau, Jose M Lizcano, Tomi P. Mäkelä, Dario Alessi
2004-07

The LKB1 tumor suppressor negatively regulates mTOR signaling

Nabeel Bardeesy, Lewis C. Cantley, Ronald A. DePinho
2004-04-01

Signaling control of mRNA translation in cancer pathogenesis

Pier Paolo Pandolfi, Nahum Sonenberg
2004-03-01

Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

Carlos Cordon-Cardo
2004-04-18

The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis

Pier Paolo Pandolfi, Carlos Cordon-Cardo, Davide Ruggero
2004-02

The glamour and gloom of glycogen synthase kinase-3
2004-04-16

Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation

Joan Massagué Solé, Joan Seoane
2004-05-01

FoxOs at the crossroads of cellular metabolism, differentiation, and transformation

Domenico Accili
2004

Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints

Aziz Sancar
2004-07-01

p63 and p73 are not required for the development and p53-dependent apoptosis of T cells

Makoto Senoo
2004-03-26

Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase

David Sinclair, Steven P. Gygi, Mark P Jedrychowski
2004-02-20

Mammalian SIRT1 represses forkhead transcription factors

Madeleine Lemieux, Nullin Divecha, Leonard P. Guarente

Article - wd:Q34368858

Welcome to Inventaire

the library of your friends and communities

learn more